Grifols.
Spanish pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 52
What's happening
Earlier this month
-
Nacho Abia was appointed CEO and Rahul Srinivasan was appointed CFO of Grifols.Some support1 report
-
Altimmune, Inc. and Grifols are being compared as healthcare companies.Some support1 report
-
Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.Some support1 report1 development inside
-
Health Canada inspected plasma donation centers while Grifols prepares to reopen centers in Edmonton.Some support1 report
One to three months ago
-
Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.Some support4 reports
-
Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.Some support2 reports
-
Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.Some support1 report
-
Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.Some support2 reports2 developments inside
-
Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.Some support1 report
-
Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.Some support2 reports
-
Norges Bank and Royal Bank of Canada made new investment moves in Grifols.Some support1 report
Gone quiet
No new reports in 90+ days-
Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.Some support1 report
-
Grifols was listed on the Nasdaq stock exchange.Some support2 reports
-
BioPharma appoints a new US head and secures US plasma supply, while Grifols reorganizes its operating model.Some support1 report
-
Seeking regulatory approval for a new therapy involving the FDA and Grifols.Some support1 report
-
Grifols and Indra Sistemas maintain operational presences in Spain and Europe.Well supported4 reports
-
Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.Some support1 report
-
Neurocrine Biosciences and Grifols are both medical drugs stocks.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Grifols this week
News at the entities that move Grifols most-
Nasdaq StructuralStrong quarterly results and foreign fund inflows supported technology stocks and lifted investor sentiment across markets.Moves Grifols
-
FDA StructuralAn industrial event related to a manufacturing crisis is triggering regulatory clocks overseen by the FDA.Moves Grifols
-
Health Canada StructuralHealth Canada authorized technology developed in Australia, prompting Hamilton burn centre specialists to be sent to Alberta.Moves Grifols
-
Bank of Montreal TransactionalBank of Montreal provided funding to AgWest Ltd., a company with branches operating in Manitoba and Saskatchewan.Moves Grifols
-
Norges Bank TransactionalJefferies Financial Group raised its shares to strong-buy rating, while Citigroup raised its shares to outperform rating, and Norges Bank bought a new position in Essex Property Trust, Inc.Moves Grifols
-
Royal Bank of Canada TransactionalRoyal Bank of Canada purchased a new position in the Teucrium Corn Fund, which is structured as a Delaware statutory trust.Moves Grifols
Connections
The 22 strongest of 52, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Grifols is formally listed on the Nasdaq stock exchange, establishing a market dependency.
-
FDA Structural
The FDA exercises formal regulatory oversight over Grifols' development and market access applications.
-
Canadian Blood Services Operational
The entities maintain a high-stakes operational partnership for plasma collection, which is simultaneously facing competitive challenges and calls for contract termination.
-
Roland Structural
Roland serves as the President of Grifols.
-
Health Canada Structural
Health Canada exercises formal regulatory oversight over Grifols, issuing non-compliance notices and suspending operations.
-
Norges Bank Transactional
Norges Bank acquired a new financial position in Grifols shares.
-
Rahul Srinivasan Structural
Rahul Srinivasan holds the position of Chief Financial Officer (CFO) at Grifols.
-
Nacho Abia Structural
Nacho Abia holds the position of Chief Executive Officer at Grifols.
Show all 22 connections
-
Bank of Montreal Transactional
Bank of Montreal increased its financial stake in Grifols.
-
Pablo García Structural
Pablo García holds the role of director in Divacons, which is a company that is part of the Grifols corporate structure.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its financial stake in Grifols.
-
Brookfield Transactional
Brookfield was involved in speculation and considered a takeover bid for Grifols.
-
Stevanato Group Operational
Grifols is actively compared to Stevanato Group based on superior earnings outlook and valuation metrics.
-
Spain Shared context
Grifols is a company that operates and is headquartered within Spain.
-
Altimmune, Inc. Mentioned together
Both companies are mentioned in the same context as healthcare companies being compared.
-
Saskatchewan Shared context
Grifols operates plasma clinics within the jurisdiction of Saskatchewan.
-
Catalonia Shared context
Grifols is a company whose establishment is rooted in the region of Catalonia.
-
MarketBeat Mentioned together
MarketBeat provides summarized ratings and financial coverage for Grifols.
-
Edmonton Shared context
Grifols operates plasma centers within the city of Edmonton.
-
BioPharma Shared context
Both companies operate within the same highly regulated US life sciences market, specifically regarding plasma supply and operational models.
-
WhiteBox Transactional
WhiteBox decreased its stake in Grifols shares.
-
British Columbia Shared context
Grifols operates within the geographical context of British Columbia, Canada.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
2 eventsSeptember 2026
3 events- Grifols, Canadian Blood Services, and Health Canada are working on a framework for sustainable plasma collection.
- Grifols, a plasma therapeutic company, operates in the US, Spain, and Canada, and MarketBeat is reporting on analyst recommendations for the company.
- Gilead Sciences and Grifols traded on the NASDAQ stock exchange on September 8, 2026.
Show 3 earlier months
August 2026
5 events- Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.
- Ground zero for commercial paid plasma collection in Saskatchewan, facing scrutiny over standards.
- Kissei partnership drives international sales of TAVALISSE, Rigel received $5 million from Grifols, and VEPPANU received FDA approval.
- Norges Bank and Royal Bank of Canada made new investment moves in Grifols.
- Spanish companies, including Grifols and Técnicas Reunidas, participate in a Bahrain consortium amid geopolitical uncertainty and rising oil prices.
July 2026
1 eventJune 2026
6 events- Health Canada found multiple deficiencies at Grifols sites, leading to a partnership established for collecting plasma for medicine.
- Grifols was listed on the Nasdaq stock exchange.
- Seeking regulatory approval for a new therapy involving the FDA and Grifols.
- Grifols and Indra Sistemas maintain operational presences in Spain and Europe.
- Whirlpool, Creative Medical Technology Holdings, and Grifols faced downward revisions to their earnings estimates on July 31, 2025.
- Neurocrine Biosciences and Grifols are both medical drugs stocks.